Literature DB >> 30526861

Aberrant Inclusion of a Poison Exon Causes Dravet Syndrome and Related SCN1A-Associated Genetic Epilepsies.

Gemma L Carvill1, Krysta L Engel2, Aishwarya Ramamurthy1, J Nicholas Cochran3, Jolien Roovers4, Hannah Stamberger4, Nicholas Lim5, Amy L Schneider6, Georgie Hollingsworth6, Dylan H Holder3, Brigid M Regan6, James Lawlor3, Lieven Lagae7, Berten Ceulemans8, E Martina Bebin9, John Nguyen5, Gregory S Barsh3, Sarah Weckhuysen4, Miriam Meisler10, Samuel F Berkovic6, Peter De Jonghe4, Ingrid E Scheffer11, Richard M Myers3, Gregory M Cooper12, Heather C Mefford13.   

Abstract

Developmental and epileptic encephalopathies (DEEs) are a group of severe epilepsies characterized by refractory seizures and developmental impairment. Sequencing approaches have identified causal genetic variants in only about 50% of individuals with DEEs.1-3 This suggests that unknown genetic etiologies exist, potentially in the ∼98% of human genomes not covered by exome sequencing (ES). Here we describe seven likely pathogenic variants in regions outside of the annotated coding exons of the most frequently implicated epilepsy gene, SCN1A, encoding the alpha-1 sodium channel subunit. We provide evidence that five of these variants promote inclusion of a "poison" exon that leads to reduced amounts of full-length SCN1A protein. This mechanism is likely to be broadly relevant to human disease; transcriptome studies have revealed hundreds of poison exons,4,5 including some present within genes encoding other sodium channels and in genes involved in neurodevelopment more broadly.6 Future research on the mechanisms that govern neuronal-specific splicing behavior might allow researchers to co-opt this system for RNA therapeutics.
Copyright © 2018 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dravet syndrome; SCN1A; alternative splicing; epilepsy; genome sequencing; noncoding; poison exon; variant interpretation

Mesh:

Substances:

Year:  2018        PMID: 30526861      PMCID: PMC6288405          DOI: 10.1016/j.ajhg.2018.10.023

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  36 in total

1.  Distribution and intensity of constraint in mammalian genomic sequence.

Authors:  Gregory M Cooper; Eric A Stone; George Asimenos; Eric D Green; Serafim Batzoglou; Arend Sidow
Journal:  Genome Res       Date:  2005-06-17       Impact factor: 9.043

2.  Novel splice variants of the voltage-sensitive sodium channel alpha subunit.

Authors:  Y Oh; S G Waxman
Journal:  Neuroreport       Date:  1998-05-11       Impact factor: 1.837

3.  Systematic discovery of regulated and conserved alternative exons in the mammalian brain reveals NMD modulating chromatin regulators.

Authors:  Qinghong Yan; Sebastien M Weyn-Vanhentenryck; Jie Wu; Steven A Sloan; Ye Zhang; Kenian Chen; Jia Qian Wu; Ben A Barres; Chaolin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

4.  Four generations of epilepsy caused by an inherited microdeletion of the SCN1A gene.

Authors:  A Suls; R Velizarova; I Yordanova; L Deprez; T Van Dyck; J Wauters; V Guergueltcheva; L R F Claes; I Kremensky; A Jordanova; P De Jonghe
Journal:  Neurology       Date:  2010-05-19       Impact factor: 9.910

5.  Genetic epilepsy with febrile seizures plus: Refining the spectrum.

Authors:  Yue-Hua Zhang; Rosemary Burgess; Jodie P Malone; Georgie C Glubb; Katherine L Helbig; Lata Vadlamudi; Sara Kivity; Zaid Afawi; Andrew Bleasel; Padraic Grattan-Smith; Bronwyn E Grinton; Susannah T Bellows; Danya F Vears; John A Damiano; Hadassa Goldberg-Stern; Amos D Korczyn; Leanne M Dibbens; Elizabeth K Ruzzo; Michael S Hildebrand; Samuel F Berkovic; Ingrid E Scheffer
Journal:  Neurology       Date:  2017-08-25       Impact factor: 9.910

6.  A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy.

Authors:  Katherine B Howell; Stefanie Eggers; Kim Dalziel; Jessica Riseley; Simone Mandelstam; Candace T Myers; Jacinta M McMahon; Amy Schneider; Gemma L Carvill; Heather C Mefford; Ingrid E Scheffer; A Simon Harvey
Journal:  Epilepsia       Date:  2018-05-11       Impact factor: 5.864

7.  Differential expression of exon 5 splice variants of sodium channel alpha subunit mRNAs in the developing mouse brain.

Authors:  E V Gazina; K L Richards; M B C Mokhtar; E A Thomas; C A Reid; S Petrou
Journal:  Neuroscience       Date:  2009-12-17       Impact factor: 3.590

8.  Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex.

Authors:  Xiaochang Zhang; Ming Hui Chen; Xuebing Wu; Andrew Kodani; Jean Fan; Ryan Doan; Manabu Ozawa; Jacqueline Ma; Nobuaki Yoshida; Jeremy F Reiter; Douglas L Black; Peter V Kharchenko; Phillip A Sharp; Christopher A Walsh
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

9.  Identifying a high fraction of the human genome to be under selective constraint using GERP++.

Authors:  Eugene V Davydov; David L Goode; Marina Sirota; Gregory M Cooper; Arend Sidow; Serafim Batzoglou
Journal:  PLoS Comput Biol       Date:  2010-12-02       Impact factor: 4.475

10.  Genomic diagnosis for children with intellectual disability and/or developmental delay.

Authors:  Kevin M Bowling; Michelle L Thompson; Michelle D Amaral; Candice R Finnila; Susan M Hiatt; Krysta L Engel; J Nicholas Cochran; Kyle B Brothers; Kelly M East; David E Gray; Whitley V Kelley; Neil E Lamb; Edward J Lose; Carla A Rich; Shirley Simmons; Jana S Whittle; Benjamin T Weaver; Amy S Nesmith; Richard M Myers; Gregory S Barsh; E Martina Bebin; Gregory M Cooper
Journal:  Genome Med       Date:  2017-05-30       Impact factor: 11.117

View more
  25 in total

Review 1.  Poison exons in neurodevelopment and disease.

Authors:  Gemma L Carvill; Heather C Mefford
Journal:  Curr Opin Genet Dev       Date:  2020-06-29       Impact factor: 5.578

Review 2.  Clinical utility of genomic sequencing.

Authors:  Matthew B Neu; Kevin M Bowling; Gregory M Cooper
Journal:  Curr Opin Pediatr       Date:  2019-12       Impact factor: 2.856

3.  All our knowledge begins with the antisenses.

Authors:  Ethan M Goldberg
Journal:  J Clin Invest       Date:  2021-12-01       Impact factor: 14.808

Review 4.  Dravet Syndrome: Novel Approaches for the Most Common Genetic Epilepsy.

Authors:  Lori L Isom; Kelly G Knupp
Journal:  Neurotherapeutics       Date:  2021-08-10       Impact factor: 6.088

Review 5.  Precision medicine for genetic epilepsy on the horizon: Recent advances, present challenges, and suggestions for continued progress.

Authors:  Juliet K Knowles; Ingo Helbig; Cameron S Metcalf; Laura S Lubbers; Lori L Isom; Scott Demarest; Ethan M Goldberg; Alfred L George; Holger Lerche; Sarah Weckhuysen; Vicky Whittemore; Samuel F Berkovic; Daniel H Lowenstein
Journal:  Epilepsia       Date:  2022-07-17       Impact factor: 6.740

Review 6.  Sodium channelopathies in neurodevelopmental disorders.

Authors:  Miriam H Meisler; Sophie F Hill; Wenxi Yu
Journal:  Nat Rev Neurosci       Date:  2021-02-02       Impact factor: 34.870

7.  Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression.

Authors:  Kian Huat Lim; Zhou Han; Hyun Yong Jeon; Jacob Kach; Enxuan Jing; Sebastien Weyn-Vanhentenryck; Mikaela Downs; Anna Corrionero; Raymond Oh; Juergen Scharner; Aditya Venkatesh; Sophina Ji; Gene Liau; Barry Ticho; Huw Nash; Isabel Aznarez
Journal:  Nat Commun       Date:  2020-07-09       Impact factor: 14.919

Review 8.  Progress, Challenges, and Surprises in Annotating the Human Genome.

Authors:  Daniel R Zerbino; Adam Frankish; Paul Flicek
Journal:  Annu Rev Genomics Hum Genet       Date:  2020-05-18       Impact factor: 8.929

Review 9.  A Role for Vasoactive Intestinal Peptide Interneurons in Neurodevelopmental Disorders.

Authors:  Kevin M Goff; Ethan M Goldberg
Journal:  Dev Neurosci       Date:  2021-04-01       Impact factor: 2.984

10.  Unraveling synonymous and deep intronic variants causing aberrant splicing in two genetically undiagnosed epilepsy families.

Authors:  Qiang Li; Yiting Wang; Yijun Pan; Jia Wang; Weishi Yu; Xiaodong Wang
Journal:  BMC Med Genomics       Date:  2021-06-09       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.